Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 2 of about 2   

Articles published

NVO 57.54
price chart
This Top-Performing Stock is Tackling One of the World's Deadliest Diseases
And when it comes to insulin, the market leader is undoubtedly Novo Nordisk A/S (NYSE:NVO), a global health care pharmaceutical company with more than 85 years in the market.
Morning News: Z, DG, NVO, LVS, ADT, CAG, RAH, DDS, PLCE, STO, XOM, CS
Insulin maker Novo Nordisk A/S (ADR) (NYSE:NVO) reported positive data on its liraglutide-based therapy for type 2 diabetes.